tory response is modulated by several mediators, including neutrophil derived leukotriene B4 (LTB4), thromboxane B2 (TXB2), and prostaglandin E2 (PGE2). The aim ofthis study was to determine the value of gut lavage sFcyRIII and eicosanoid measurements for the assessment of mucosal inflammation in IBD. Methods-A total of 18 patients with active IBD, 10 ulcerative colitis (UC), and eight Crohn's disease (CD), and 12 control patients underwent whole gut lavage. Disease activity, endoscopic appearance, and histopathology were graded. Samples were processed for the determination of sFcyRIIIb, LTB4, PGE2, and TXB2. Results-Soluble FcyRIIIb concentrations were increased in both IBD groups. Significant correlations were seen between sFcyRIIIb and LTB4 values with histology scores. Mean eicosanoid lavage fluid concentrations in control patients were 14-1 pg/ml for LTB4, 5.6 pg/ml for PGE2, and 397 pg/ml for TXB2. Concentrations of all eicosanoids in IBD patients were significandy increased: LTB4 in UC: mean 73.2 pg/ml, in CD: 96.4 pg/ml (both p<001 v controls). PGE2 in UC: 20.2 pg/ml, in CD: 43.4 pg/ml (p<0 01). TXB2 in UC: 719.3 pg/ml, in CD: 180-6 pg/ml (both p<005 20 The aim of this study was to assess gut lavage concentrations of both sFc-yRIIIb and eicosanoids, and their correlations with disease activity, to evaluate their usefulness as markers for mucosal inflammation in patients with active IBD.
Methods

Patients
Eighteen patients with a previous diagnosis of IBD (ulcerative colitis, UC: Crohn's disease, CD) based on histological, radiological, and endoscopic findings (10 UC and eight CD) underwent whole gut lavage for clinically indicated endoscopy. In three CD patients, the terminal ileum was involved, the remaining CD patients suffered from large bowel disease. Control patients (12) underwent colonoscopy for the investigation of abdominal pain of unknown origin or polyps. The caecum was reached in all cases.
Endoscopic appearance was scored in UC patients using a previously described scoring scale,2' in which an increasing score (0 to 18) pointed to greater macroscopic inflammation.
Four biopsy specimens for histopathology were obtained from macroscopically inflamed areas, and scored in a blinded fashion, using a predefined scoring scale with 14 relevant parameters,22 with a maximal score of 22 points.
Disease activity was assessed using the PowellTuck index (PTI)23 for UC patients, and the Crohn's Disease Activity Index (CDAI)24 for CD patients. This study was approved by the medical ethical committee of the Academic Medical Centre in Amsterdam.
Gut lavage procedure An isotonic non-absorbable lavage fluid (sodium 125 mmoVl, potassium 10 mmolIl, sulphate 40 mmol/l, chloride 35 mmol/l, bicarbonate 20 mmoIl) was given through a gastric tube at a rate of 1-1 5 litre per hour. When clear fluid passed the rectum (usually within two hours), free of faecal debris, 20 ml was collected from each patient. Within 10 minutes the lavage fluid was processed as described previously. '8-20 In brief, fluid was filtered through a GF/A glass fibre filter (Whatman Scientific, Kent, England) 
Results
Patients
In UC patients, disease activity (PTI) ranged from 2-11 points (mean 5.4 (1 0)), in CD patients disease activity (CDAI) ranged from 21-390 points (mean 174.5 (40)). The distribution of treatment regimens were similar in both disease groups with respect to the use of sulphasalazine/5-ASA, corticosteroids, and immunosuppressive drugs. The lavage procedure was well tolerated in all patients and all samples were processed immediately after colonoscopy. In UC patients, the endoscopic scores varied between 2 and 14 points (mean 5*7 (1. 1)) and the histopathology scores in this group ranged from 5 to 15 (8.9 (0.9)). The mean histopathology score in CD patients was 11 *4 (1 *3) points (range 6-17).
sFc yRIII
The Figure (A) shows the sFcyRIII concentrations. In control patients the sFcyRIII concentration ranged from 1.0 to 6-0 units (mean 3-2 (0.5)). In both study groups, sFcyRIII values were increased: in UC patients a mean value was seen of 35 (20) To determine the cellular origin of sFcyRIII, the NA-polymorphism was determined in the serum samples of eight patients with active CD: five patients were found to be homozygous NA2NA2, one patient homozygous NAlNAl, and two patients were heterozygous NA1NA2. In the lavage fluid of the three NAI positive patients, NAI-sFcyRIII was detected in considerable amounts (mean 233 arbitrary units). In all NA2NA2 patients, lavage fluid concentrations of NAl-sFc-yRIII were negative. Hence, the NA-polymorphism that was predicted from serum was also found in lavage fluid. This finding suggests that the sFcyRIII detected in lavage fluid originated from neutrophils. 
Eicosanoids
The mean LTB4 value measured 14-2 (3. 1) pg/ml in controls, whereas this was 73.2 (29.3) pg/ml in UC patients (p<0.01 v control) and 96-4 (22.7) pg/ml in CD patients (p<001 v control) (Fig (B) . Figure (C) shows PGE2 values. In UC patients, a mean of 20.2 (10.5) pg/ml versus 5-6 (0.23) pg/ml in control patients was measured. In CD patients these values increased even further (mean of 43-4 (17-9) pg/ml). The difference between CD patients and controls was significant (p<0 01). Lavage TXB2 concentrations in control patients ranged from 155.4 to 397 pg/ml (mean 287-3 (22.2) pg/ml) (Fig 1D) , in UC patients these concentrations were significantly higher (mean 719.3 (76.7) pg/ml, p<0.01). In CD patients the mean TXB2 value was 549.7 (120.8) pg/ml, which also differed significantly from controls (p<0 05).
Correlations
In UC patients, sFcyRIII correlated well with the endoscopic score (r=0.77, p<0.01), weaker correlations were found between sFcyRIII and histology scores (r=0.60, p=0.08) and disease activity (r=0-61, p=0.06). LTB4 concentrations correlated with the histology score in UC patients (r=0.63, p<0 05).
In showed a significant amount in all NA1 positive patients, and no NAl-sFcyRIIIb in NA2NA2 positive patients. Hence the NA polymorphism that was predicted from plasma was also found in lavage fluid. This finding strongly suggests that the FcyRIII in lavage fluid originated from neutrophils. A significant correlation was seen between sFcyRIII and LTB4 lavage concentrations, a leukotriene with well recognised neutrophil chemoattracting and activating action. sFcyRIII values correlated well with the histology scores (UC: r=060, CD: r=089). LTB4 concentrations correlated with histology scores (UC: r=0.63, CD: r=0.89). These findings show that sFcyRIII and LTB4 in lavage fluid in IBD patients reflect the mucosal neutrophil induced inflammation. The score derived from the endoscopic scoring system used reflects the greatest degree of inflammation seen rather than assesses the geographical extent of this process. Consequently, comparatively small areas of mucosal inflammation may have a significant influence on the concentrations of luminal inflammatory mediators detected.
The concentrations of both the pro-inflammatory LTB4 and TXB2 as well as the cytoprotective PGE2 were significantly increased in CD and UC. These results are comparable to previous studies that have found increased concentrations of LTB4 and PGE2 in rectal dialysis of UC patients,29 and in the mucus of ulcerative proctocolitis.30 Measurement of eicosanoids in lavage fluid does not require insertion of a rectal dialysis bag, and therefore is more feasible. In addition, lavage fluid eicosanoid concentration may better reflect the amount of eicosanoids produced by the total area of inflamed bowel, especially in CD, which may be patchy. Hence this method could be used to monitor mucosal inflammation in clinical intervention studies in IBD. Our results emphasise the difficulties of attempting to correlate mucosal inflammatory mediator production with clinical parameters of IBD activity.
In conclusion, we have shown that the sFcyRIII and LTB4 lavage fluid concentration reflects mucosal inflammation. Because the sFcyRIII in lavage fluid was shown to originate from neutrophils, and neutrophils are known to be the major source of LTB4 within the bowel mucosa, these measurements probably reflect mucosal neutrophil infiltration.
